SG157374A1 - Ophthalmic solution - Google Patents

Ophthalmic solution

Info

Publication number: SG157374A1
Authority: SG; Singapore
Prior art keywords: agent; compositions; antimicrobial; contact lens; rewetters
Prior art date: 2004-11-09

Application number

SG200907392-5A

Other languages

English (en)

Inventor

Charles H Powell

Stanley W Huth

Original Assignee

Abbott Medical Optics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-09

Filing date

2005-11-09

Publication date

2009-12-29

2005-11-09 Application filed by Abbott Medical Optics Inc filed Critical Abbott Medical Optics Inc

2009-12-29 Publication of SG157374A1 publication Critical patent/SG157374A1/en

Links

229940054534 ophthalmic solution Drugs 0.000 title 1
239000002997 ophthalmic solution Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
239000004599 antimicrobial Substances 0.000 abstract 2
239000000243 solution Substances 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
229950010221 alexidine Drugs 0.000 abstract 1
LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
230000000845 anti-microbial effect Effects 0.000 abstract 1
235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
125000002091 cationic group Chemical group 0.000 abstract 1
229960001927 cetylpyridinium chloride Drugs 0.000 abstract 1
YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000000645 desinfectant Substances 0.000 abstract 1
239000003889 eye drop Substances 0.000 abstract 1
229940012356 eye drops Drugs 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
238000004806 packaging method and process Methods 0.000 abstract 1
238000004659 sterilization and disinfection Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/141—Biguanides, e.g. chlorhexidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Ophthalmology & Optometry (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Apparatus For Disinfection Or Sterilisation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Eyeglasses (AREA)
Detergent Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG200907392-5A 2004-11-09 2005-11-09 Ophthalmic solution SG157374A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62637104P	2004-11-09	2004-11-09

Publications (1)

Publication Number	Publication Date
SG157374A1 true SG157374A1 (en)	2009-12-29

Family

ID=35848047

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200907392-5A SG157374A1 (en)	2004-11-09	2005-11-09	Ophthalmic solution

Country Status (8)

Country	Link
US (1)	US20060100173A1 (fr)
EP (1)	EP1809242B1 (fr)
JP (1)	JP2008519846A (fr)
CN (1)	CN101056614A (fr)
AU (1)	AU2005304424A1 (fr)
CA (1)	CA2585760A1 (fr)
SG (1)	SG157374A1 (fr)
WO (1)	WO2006053164A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20051569A1 (it) *	2005-08-11	2007-02-12	Biokosmes S R L	Composizione cicatrizzante
US7456095B2 (en) *	2005-10-03	2008-11-25	International Business Machines Corporation	Method and apparatus for forming nickel silicide with low defect density in FET devices
US20080152540A1 (en) *	2006-12-22	2008-06-26	Bausch & Lomb Incorporated	Packaging solutions
US9579341B2 (en) *	2007-05-16	2017-02-28	Johnson & Johnson Consumer Inc.	Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8759321B2 (en) *	2007-06-13	2014-06-24	Bausch & Lomb Incorporated	Ophthalmic composition with hyaluronic acid and polymeric biguanide
US20090036404A1 (en) *	2007-08-02	2009-02-05	Macleod Steven K	Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP2009096790A (ja) *	2007-09-28	2009-05-07	Rohto Pharmaceut Co Ltd	疲れ目改善用及び／又はかすみ目改善用コンタクトレンズ装着液
US20090173045A1 (en) *	2008-01-09	2009-07-09	Yu-Chin Lai	Packaging Solutions
US8119112B2 (en) *	2008-01-31	2012-02-21	Bausch & Lomb Incorporated	Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) *	2008-01-31	2015-08-04	Bausch & Lomb Incorporated	Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US20110046033A1 (en) *	2008-01-31	2011-02-24	Jinzhong Zhang	Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
US20100178317A1 (en) *	2009-01-09	2010-07-15	Burke Susan E	Lens Care Solutions with Hyaluronic Acid
US20100234319A1 (en) *	2009-03-11	2010-09-16	Abbott Medical Optics Inc.	Complex of Polymeric Quaternary Ammonium and Anionic Polymers as a New Antimicrobial Agent for Ophthalmic Compositions
US8349303B1 (en) *	2009-04-29	2013-01-08	Bausch & Lomb Incorporated	Polymeric quaternium compounds
JP5407688B2 (ja) *	2009-09-15	2014-02-05	日油株式会社	コンタクトレンズ用処理溶液
KR101134340B1 (ko) *	2011-06-10	2012-04-09	주식회사 휴온스	안과질환 예방 또는 치료용 점안제 조성물
EP2752704B1 (fr)	2011-09-02	2019-10-09	Menicon Co., Ltd.	Système d'amélioration du caractère hydrophile de lentilles de contact et application de celui-ci à un emballage de lentilles de contact
CN111419794A (zh) *	2013-02-01	2020-07-17	阿勒根公司	包含透明质酸钠和羧甲基纤维素的人工泪液
CN108024532A (zh) *	2015-07-24	2018-05-11	泰利福医疗公司	用于手术应用的抗微生物组合物
EP3589125A1 (fr) *	2017-03-01	2020-01-08	Ecolab USA, Inc.	Assainisseurs et désinfectants à risques d'inhalation réduits par l'intermédiaire de polymères de poids moléculaire élevé
JP7229262B2 (ja) *	2017-11-22	2023-02-27	ボシュ・アンド・ロム・インコーポレイテッド	眼科用粘弾性組成物
JP7304168B2 (ja) *	2018-02-23	2023-07-06	ロート製薬株式会社	点眼剤
WO2020005416A1 (fr) *	2018-06-27	2020-01-02	Bausch & Lomb Incorporated	Solutions d'emballage
US11795320B2 (en) *	2019-09-20	2023-10-24	Bausch + Lomb Ireland Limited	Grafted polymer and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH1160505A (ja) *	1997-05-20	1999-03-02	Senju Pharmaceut Co Ltd	防腐組成物
KR100354606B1 (ko) *	2000-02-01	2002-09-30	주식회사 중외제약	다목적 콘택트 렌즈 관리 용액 조성물
DK1347787T4 (da) *	2001-01-09	2011-01-03	Louis Johan Wagenaar	Anvendelse af dexpanthenol i kontaktlinse-plejesammensætninger
MXPA04008173A (es) *	2002-02-22	2004-11-26	Pharmacia Corp	Formulaciones de farmaco antibiotico oftalmico que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio.
US20050196370A1 (en) *	2003-03-18	2005-09-08	Zhi-Jian Yu	Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye

2005
- 2005-11-09 AU AU2005304424A patent/AU2005304424A1/en not_active Abandoned
- 2005-11-09 CA CA002585760A patent/CA2585760A1/fr not_active Abandoned
- 2005-11-09 JP JP2007541330A patent/JP2008519846A/ja active Pending
- 2005-11-09 EP EP05826067A patent/EP1809242B1/fr not_active Expired - Lifetime
- 2005-11-09 CN CNA2005800380090A patent/CN101056614A/zh active Pending
- 2005-11-09 US US11/271,448 patent/US20060100173A1/en not_active Abandoned
- 2005-11-09 SG SG200907392-5A patent/SG157374A1/en unknown
- 2005-11-09 WO PCT/US2005/040827 patent/WO2006053164A2/fr not_active Ceased

Also Published As

Publication number	Publication date
CA2585760A1 (fr)	2006-05-18
WO2006053164A2 (fr)	2006-05-18
EP1809242A2 (fr)	2007-07-25
JP2008519846A (ja)	2008-06-12
EP1809242B1 (fr)	2013-03-20
WO2006053164A3 (fr)	2006-08-10
AU2005304424A1 (en)	2006-05-18
CN101056614A (zh)	2007-10-17
US20060100173A1 (en)	2006-05-11

Publication	Publication Date	Title
SG157374A1 (en)	2009-12-29	Ophthalmic solution
BRPI0520014A2 (pt)	2009-04-14	emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco
BRPI0406636A (pt)	2005-12-06	Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação
TW200626188A (en)	2006-08-01	Biomedical devices containing amphiphilic block copolymers
MX2009005836A (es)	2009-10-08	Preparaciones antimicrobianas sinergisticas que contienen clorito y peroxido de hidrogeno.
JP5938616B2 (ja)	2016-06-22	コンタクトレンズ用液剤
BR0314951A (pt)	2005-08-02	Método e composição oftálmica para aumentar a eficácia antimocrobiana de uma composição contra acanthamoebae
DE60316836D1 (de)	2007-11-22	Zusammensetzung und verfahren zur pflege von kontaktlinsen
KR20100016091A (ko)	2010-02-12	콘택트 렌즈 관리 및 약제학적 조성물의 보존용 인지질 조성물
ATE555187T1 (de)	2012-05-15	Ophthalmische zusammensetzung mit hyaluronsäure
CY1110596T1 (el)	2015-04-29	L-ιστιδινη σε οφθαλμικα διαλυματα
HRP20131173T1 (hr)	2014-01-17	Vodeni farmaceutski pripravci koji sadrže boratno-poliolne komplekse
DE602007003560D1 (de)	2010-01-14	Verbesserung der desinfektionswirksamkeit von linsenpflegeprogrammen für starre gasdurchlässige kontaktlinsen
CN101977590A (zh)	2011-02-16	具有改善功效的眼用溶液
BR0209317A (pt)	2004-07-20	Composições incluindo tensoativos com base em vitamina e métodos para usar as mesmas
JP2012189993A (ja)	2012-10-04	コンタクトレンズ用液体組成物
BRPI0417175A (pt)	2007-03-06	composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
CN103083710A (zh)	2013-05-08	含海藻糖季铵盐的角膜接触镜护理组合物
BRPI0408827A (pt)	2006-04-04	composições oftálmicas preservadas
DE602004031590D1 (de)	2011-04-14	Antimikrobielle zusammensetzungen, die ethanolamid-puffer und biguanid-desinfektionsmittel enthalten
EP2365806A1 (fr)	2011-09-21	Solutions ophthalmiques, dont solutions de soins pour verres de contact et colyres, comprenant de la carnosine de préférence associée à du dexpanthénol et/ou à de l acide hyaluronique
EP2062872A3 (fr)	2009-06-17	Utilisation de bis-amines pour renforcer l'activité antimicrobienne de compositions aqueuses
TR201908487T4 (tr)	2019-07-22	Oftalmolojik bileşimler ve kullanımları.
PT1850888E (pt)	2008-11-20	Composição para manutenção de lentes de contacto
BRPI0517811A (pt)	2008-10-21	solução oftálmica